These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 28118281
1. Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study. Rosa J, Widimský P, Waldauf P, Zelinka T, Petrák O, Táborský M, Branny M, Toušek P, Čurila K, Lambert L, Bednář F, Holaj R, Štrauch B, Václavík J, Kociánová E, Nykl I, Jiravský O, Rappová G, Indra T, Krátká Z, Widimský J. J Hypertens; 2017 May; 35(5):1093-1099. PubMed ID: 28118281 [Abstract] [Full Text] [Related]
2. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial. Oliveras A, Armario P, Clarà A, Sans-Atxer L, Vázquez S, Pascual J, De la Sierra A. J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441 [Abstract] [Full Text] [Related]
3. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study. Rosa J, Widimský P, Waldauf P, Lambert L, Zelinka T, Táborský M, Branny M, Toušek P, Petrák O, Čurila K, Bednář F, Holaj R, Štrauch B, Václavík J, Nykl I, Krátká Z, Kociánová E, Jiravský O, Rappová G, Indra T, Widimský J. Hypertension; 2016 Feb; 67(2):397-403. PubMed ID: 26693818 [Abstract] [Full Text] [Related]
4. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study. Rosa J, Widimský P, Toušek P, Petrák O, Čurila K, Waldauf P, Bednář F, Zelinka T, Holaj R, Štrauch B, Šomlóová Z, Táborský M, Václavík J, Kociánová E, Branny M, Nykl I, Jiravský O, Widimský J. Hypertension; 2015 Feb; 65(2):407-13. PubMed ID: 25421981 [Abstract] [Full Text] [Related]
5. The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence. Ott C, Mahfoud F, Schmid A, Ewen S, Toennes SW, Meyer MR, Helfer AG, Maurer HH, Ditting T, Veelken R, Zivanovic I, Uder M, Böhm M, Schmieder RE. J Hypertens; 2016 Dec; 34(12):2475-2479. PubMed ID: 27607458 [Abstract] [Full Text] [Related]
6. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A. Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332 [Abstract] [Full Text] [Related]
7. Sufficient and Persistent Blood Pressure Reduction in the Final Long-Term Results From SYMPLICITY HTN-Japan - Safety and Efficacy of Renal Denervation at 3 Years. Kario K, Yamamoto E, Tomita H, Okura T, Saito S, Ueno T, Yasuhara D, Shimada K, SYMPLICITY HTN-Japan Investigators. Circ J; 2019 Feb 25; 83(3):622-629. PubMed ID: 30760655 [Abstract] [Full Text] [Related]
8. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial. Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP, Lederballe O, Rickers H, Kampmann U, Poulsen PL, Hansen KW, Btker HE, Peters CD, Engholm M, Bertelsen JB, Lassen JF, Langfeldt S, Andersen G, Pedersen EB, Kaltoft A. J Hypertens; 2016 Aug 25; 34(8):1639-47. PubMed ID: 27228432 [Abstract] [Full Text] [Related]
9. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension. Lambert T, Gammer V, Nahler A, Blessberger H, Kammler J, Grund M, Kerschner K, Buchmayr G, Saleh K, Kypta A, Hönig S, Wichert-Schmitt B, Schwarz S, Sihorsch K, Reiter C, Steinwender C. Int J Cardiol; 2015 Feb 15; 181():96-101. PubMed ID: 25497527 [Abstract] [Full Text] [Related]
10. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy? Verdalles U, García de Vinuesa S, Goicoechea M, Macías N, Santos A, Perez de Jose A, Verde E, Yuste C, Luño J. Nephrology (Carlton); 2015 Aug 15; 20(8):567-71. PubMed ID: 25818266 [Abstract] [Full Text] [Related]
11. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension. Ewen S, Dörr O, Ukena C, Linz D, Cremers B, Laufs U, Hamm C, Nef H, Bauer A, Mancia G, Böhm M, Mahfoud F. J Hypertens; 2015 Dec 15; 33(12):2512-8. PubMed ID: 26485461 [Abstract] [Full Text] [Related]
12. SYMPLICITY HTN-Japan - First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients - . Kario K, Ogawa H, Okumura K, Okura T, Saito S, Ueno T, Haskin R, Negoita M, Shimada K, SYMPLICITY HTN-Japan Investigators. Circ J; 2015 Dec 15; 79(6):1222-9. PubMed ID: 25912693 [Abstract] [Full Text] [Related]
13. Effects of multielectrode renal denervation on cardiac and neurohumoral adaptations in resistant hypertension with cardiac hypertrophy: an EnligHTN I substudy. Tsioufis C, Papademetriou V, Dimitriadis K, Tsiachris D, Thomopoulos C, Kasiakogias A, Kordalis A, Kefala A, Koutra E, Lau EO, Grassi G, Stefanadis C. J Hypertens; 2015 Feb 15; 33(2):346-53. PubMed ID: 25380167 [Abstract] [Full Text] [Related]